Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jun 12;24(1):26.
doi: 10.1186/s10195-023-00707-5.

Hormone replacement therapy in women and risk of carpal tunnel syndrome: a systematic review and metaanalysis

Worapaka Manosroi  1   2 , Pichitchai Atthakomol  3   4 , Phichayut Phinyo  2   5   6 , Pojsakorn Danpanichkul  7
Affiliations
Meta-Analysis

Hormone replacement therapy in women and risk of carpal tunnel syndrome: a systematic review and metaanalysis

Worapaka Manosroi et al. J Orthop Traumatol. .

Abstract

Background: Carpal tunnel syndrome (CTS) is the most common entrapment mononeuropathy. Menopausal status and/or estrogen level may play a role in CTS. The evidence regarding the association between hormone replacement therapy (HRT) in postmenopausal women and CTS is still conflicting. This meta-analysis aimed to investigate the association between carpal tunnel syndrome (CTS) and women using hormone replacement therapy (HRT).

Methods: A search was conducted in the PubMed/Medline, Scopus, Embase, and Cochrane databases, from their inception through July 2022. Studies which reported on the association between any type of HRT use and the risk of developing CTS in postmenopausal women compared to a control group were included. Studies which did not include a control group were excluded. Of the 1573 articles extracted from database searches, seven studies involving 270,764 women were included of which 10,746 had CTS. The association between CTS and HRT use was evaluated using the pooled odds ratio (OR) with a 95% confidence interval (CI) under random-effects modelling. Risk of bias in each study was assessed using the Newcastle-Ottawa Scale (NOS) and version 2 of the Cochrane tool for assessing risk of bias in randomized trials (RoB 2).

Results: HRT use showed no statistically significant association with a higher risk of CTS with pooled odds ratio (OR) 1.49, 95% confidence interval (CI) 0.99-2.23, and p = 0.06, although high heterogeneity among the studies was observed (I2 97.0%, Q-test p-value < 0.001). Subgroup analysis of groups in non-randomized controlled studies showed a significantly increased risk of CTS, while groups in randomized controlled studies showed a decreased risk of CTS (pooled OR 1.87, 95% CI 1.24-2.83 versus pooled OR 0.79, 95% CI 0.69-0.92, respectively) with the p-value of group difference < 0.001. The risk of bias in most of the included studies was estimated to be low.

Conclusions: This meta-analysis supports the safety of using HRT in postmenopausal women with potential risk factors for CTS.

Level of evidence: I, Prognosis.

Registration: INPLASY (202280018).

Keywords: Carpal tunnel syndrome; Estrogen; Hormone replacement therapy; Progesterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Prisma flow diagram
Fig. 2
Fig. 2
Risk of bias assessment by RoB 2 in the randomized controlled study
Fig. 3
Fig. 3
Forest plots of the odds ratio of carpal tunnel syndrome in women using HRT and women not using HRT
Fig. 4
Fig. 4
Subgroup analysis of odds ratio of carpal tunnel syndrome between women using HRT and women not using HRT categorized by (A) study design, (B) adjusted or unadjusted for confounders of reported OR, and (C) sensitivity analysis removing studies which identified the incidence of CTS by retrieving data from documentation of CTS release procedures
Fig. 5
Fig. 5
Funnel plot of seven included studies
See this image and copyright information in PMC

References

    1. Sevy JO, Varacallo M. Carpal Tunnel Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright© 2022, StatPearls Publishing LLC.; 2022.
    1. Dale AM, Harris-Adamson C, Rempel D, Gerr F, Hegmann K, Silverstein B, et al. Prevalence and incidence of carpal tunnel syndrome in US working populations: pooled analysis of six prospective studies. Scand J Work Environ Health. 2013;39(5):495–505. doi: 10.5271/sjweh.3351. - DOI - PMC - PubMed
    1. Hegmann KT, Merryweather A, Thiese MS, Kendall R, Garg A, Kapellusch J, et al. Median nerve symptoms, signs, and electrodiagnostic abnormalities among working adults. J Am Acad Orthop Surg. 2018;26(16):576–584. doi: 10.5435/jaaos-d-17-00034. - DOI - PubMed
    1. Morales L, Pans S, Verschueren K, Van Calster B, Paridaens R, Westhovens R, et al. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol. 2008;26(19):3147–3152. doi: 10.1200/jco.2007.15.4005. - DOI - PubMed
    1. Toesca A, Pagnotta A, Zumbo A, Sadun R. Estrogen and progesterone receptors in carpal tunnel syndrome. Cell Biol Int. 2008;32(1):75–79. doi: 10.1016/j.cellbi.2007.08.014. - DOI - PubMed